Mild Cognitive Impairment: Narrative Review of Taxonomies and Systematic Review of Their Prediction of Incident Alzheimer's Disease Dementia

Overview

Journal BJPsych Bull

Publisher Cambridge University Press

Specialty Psychiatry

Date 2019 Nov 15

PMID 31724527

Citations 12

Authors

Nicholas I Bradfield

David Ames

Affiliations

Soon will be listed here.

Abstract

Early detection of Alzheimer's disease is vital for developing novel treatments. Attempts to identify the intermediate state between normal cognition and dementia have evolved over the past 50 years. Current taxonomies of mild cognitive impairment (MCI) may be criticised for their imprecise operationalisation. With the advent of biomarkers such as amyloid-beta positron emission tomography imaging in established Alzheimer's disease, much research has focused on establishing which factors predict progression from MCI to Alzheimer's disease dementia. In this review, we discuss the historical context of MCI before reviewing the literature of MCI subtypes and their risk of progression to Alzheimer's disease dementia. Finally, we summarise the literature and discuss limitations and weaknesses of how the construct is operationalised and implemented, before offering suggestions for development of the concept of MCI. We conclude that MCI must be empirically defined for the sake of its predictive validity to identify Alzheimer's disease before dementia develops.

Citing Articles

Clinical practice guidelines for assessment and management of mild neurocognitive disorder.

Subramanyam A, Singh S, Raut N Indian J Psychiatry. 2025; 67(1):21-40.

PMID: 40046485 PMC: 11878458. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_693_24.

Synthesis and characterization of fullerene-based nanocarrier for targeted delivery of quercetin to the brain.

Palai A, Kumar A, Mazahir F, Sharma A, Yadav A Ther Deliv. 2024; 15(7):545-559.

PMID: 39235760 PMC: 11412138. DOI: 10.1080/20415990.2024.2365620.

Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI.

Salvadori N, Torrigiani E, Paoletti F, Chipi E, Montanucci C, Verderosa C Sci Rep. 2024; 14(1):12235.

PMID: 38806521 PMC: 11133313. DOI: 10.1038/s41598-024-62604-z.

Sociotechnical feasibility of natural language processing-driven tools in clinical trial eligibility prescreening for Alzheimer's disease and related dementias.

Idnay B, Liu J, Fang Y, Hernandez A, Kaw S, Etwaru A J Am Med Inform Assoc. 2024; 31(5):1062-1073.

PMID: 38447587 PMC: 11031244. DOI: 10.1093/jamia/ocae032.

Clock-Drawing Test as a Screening Tool for Cognitive Impairment Associated With Fecal Immunochemical Test Collection Errors.

Daly J, Xu Y, Crockett S, Schmidt M, Kim P, Levy B Ann Fam Med. 2022; 20(5):452-459.

PMID: 36228064 PMC: 9512558. DOI: 10.1370/afm.2855.

References

Summers M, Saunders N . Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment. Neuropsychology. 2012; 26(4):498-508. DOI: 10.1037/a0028576. View

Jellinger K, Danielczyk W, Fischer P, Gabriel E . Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci. 1990; 95(3):239-58. DOI: 10.1016/0022-510x(90)90072-u. View

Vos S, Verhey F, Frolich L, Kornhuber J, Wiltfang J, Maier W . Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. Brain. 2015; 138(Pt 5):1327-38. PMC: 5013930. DOI: 10.1093/brain/awv029. View

Kokmen E, Naessens J, Offord K . A short test of mental status: description and preliminary results. Mayo Clin Proc. 1987; 62(4):281-8. DOI: 10.1016/s0025-6196(12)61905-3. View

McKhann G, Knopman D, Chertkow H, Hyman B, Jack Jr C, Kawas C . The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):263-9. PMC: 3312024. DOI: 10.1016/j.jalz.2011.03.005. View

Lobo A, Launer L, Fratiglioni L, Andersen K, Di Carlo A, Breteler M . Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000; 54(11 Suppl 5):S4-9. View

Bermejo-Pareja F, Contador I, Trincado R, Lora D, Sanchez-Ferro A, Mitchell A . Prognostic Significance of Mild Cognitive Impairment Subtypes for Dementia and Mortality: Data from the NEDICES Cohort. J Alzheimers Dis. 2016; 50(3):719-31. DOI: 10.3233/JAD-150625. View

Petersen R, Smith G, Kokmen E, Ivnik R, Tangalos E . Memory function in normal aging. Neurology. 1992; 42(2):396-401. DOI: 10.1212/wnl.42.2.396. View

Petersen R, Thomas R, Grundman M, Bennett D, Doody R, Ferris S . Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005; 352(23):2379-88. DOI: 10.1056/NEJMoa050151. View

10.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

11.

Jessen F, Amariglio R, van Boxtel M, Breteler M, Ceccaldi M, Chetelat G . A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014; 10(6):844-52. PMC: 4317324. DOI: 10.1016/j.jalz.2014.01.001. View

12.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

13.

Forlenza O, Diniz B, Nunes P, Memoria C, Yassuda M, Gattaz W . Diagnostic transitions in mild cognitive impairment subtypes. Int Psychogeriatr. 2009; 21(6):1088-95. DOI: 10.1017/S1041610209990792. View

14.

Fratiglioni L, Grut M, Forsell Y, Viitanen M, Grafstrom M, Holmen K . Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology. 1991; 41(12):1886-92. DOI: 10.1212/wnl.41.12.1886. View

15.

Gomar J, Bobes-Bascaran M, Conejero-Goldberg C, Davies P, Goldberg T . Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Arch Gen Psychiatry. 2011; 68(9):961-9. DOI: 10.1001/archgenpsychiatry.2011.96. View

16.

Petersen R . Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004; 256(3):183-94. DOI: 10.1111/j.1365-2796.2004.01388.x. View

17.

Oltra-Cucarella J, Sanchez-SanSegundo M, Lipnicki D, Sachdev P, Crawford J, Perez-Vicente J . Using Base Rate of Low Scores to Identify Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease. J Am Geriatr Soc. 2018; 66(7):1360-1366. PMC: 6097891. DOI: 10.1111/jgs.15412. View

18.

Albert M, DeKosky S, Dickson D, Dubois B, Feldman H, Fox N . The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7(3):270-9. PMC: 3312027. DOI: 10.1016/j.jalz.2011.03.008. View

19.

Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N . Conversion of mild cognitive impairment to dementia: predictive role of mild cognitive impairment subtypes and vascular risk factors. Dement Geriatr Cogn Disord. 2005; 21(1):51-8. DOI: 10.1159/000089515. View

20.

Marcos G, Santabarbara J, Lopez-Anton R, De-la-Camara C, Gracia-Garcia P, Lobo E . Conversion to dementia in mild cognitive impairment diagnosed with DSM-5 criteria and with Petersen's criteria. Acta Psychiatr Scand. 2015; 133(5):378-85. DOI: 10.1111/acps.12543. View